Nazo, the Drosophila homolog of the NBIA-mutated protein-c19orf12, is required for triglyceride homeostasis.


Journal

PLoS genetics
ISSN: 1553-7404
Titre abrégé: PLoS Genet
Pays: United States
ID NLM: 101239074

Informations de publication

Date de publication:
09 Feb 2024
Historique:
received: 17 07 2023
accepted: 12 01 2024
medline: 9 2 2024
pubmed: 9 2 2024
entrez: 9 2 2024
Statut: aheadofprint

Résumé

Lipid dyshomeostasis has been implicated in a variety of diseases ranging from obesity to neurodegenerative disorders such as Neurodegeneration with Brain Iron Accumulation (NBIA). Here, we uncover the physiological role of Nazo, the Drosophila melanogaster homolog of the NBIA-mutated protein-c19orf12, whose function has been elusive. Ablation of Drosophila c19orf12 homologs leads to dysregulation of multiple lipid metabolism genes. nazo mutants exhibit markedly reduced gut lipid droplet and whole-body triglyceride contents. Consequently, they are sensitive to starvation and oxidative stress. Nazo is required for maintaining normal levels of Perilipin-2, an inhibitor of the lipase-Brummer. Concurrent knockdown of Brummer or overexpression of Perilipin-2 rescues the nazo phenotype, suggesting that this defect, at least in part, may arise from diminished Perilipin-2 on lipid droplets leading to aberrant Brummer-mediated lipolysis. Our findings potentially provide novel insights into the role of c19orf12 as a possible link between lipid dyshomeostasis and neurodegeneration, particularly in the context of NBIA.

Identifiants

pubmed: 38335241
doi: 10.1371/journal.pgen.1011137
pii: PGENETICS-D-23-00784
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1011137

Informations de copyright

Copyright: © 2024 Sreejith et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Auteurs

Perinthottathil Sreejith (P)

Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, New York, United States of America.

Sara Lolo (S)

Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, New York, United States of America.

Kristen R Patten (KR)

Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, New York, United States of America.

Maduka Gunasinghe (M)

Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, New York, United States of America.

Neya More (N)

Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, New York, United States of America.

Leo J Pallanck (LJ)

Department of Genome Sciences, University of Washington, Seattle, Washington, United States of America.

Rajnish Bharadwaj (R)

Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, New York, United States of America.

Classifications MeSH